The application of clinical smart nanocarriers continues to be a fruitful and challenging field for both academic and clinical disciplines as well as industries. These clinically approved micro- and nanobased products have impacted treatment of numerous predominant diseases including cancer, diabetes, and different immune disorders. This Two-Volume Set presents a comprehensive overview of the most recent studies on smart micro- and nanomaterials with a focus on their smart activity for formation of targeted and responsive drug-delivery carriers and pharmaceutical applications.
- Covers the global market perspective of micro- and nano-smart materials in pharmaceutical industries.
- Discusses smart micro- and nanomaterials processing by polymers, metals, and other composites.
- Describes all possible stimulated systems for drug delivery.
- Details swellable polymers, multi-stimuli-responsive polymers, carbon nanotubes, quantum dots, and self-assembling peptide-based nanostructures.
- Explains various processing routes and mechanisms for target release.
- Addresses applications in oral drug delivery, anticancer agents, anti-tumor drug delivery, drugs for management of infection, and MEMS and diagnostics along with their future scope.
This wide-ranging reference work is written to support researchers in the fields of materials engineering and biotechnology with the goal of improving the diagnosis and treatment of disease and patient quality of life.
Ajit Behera is Assistant Professor in the Metallurgical & Materials Department at National Institute of Technology, Rourkela. He earned his PhD from IIT Kharagpur.
Arpan Kumar Nayak is Research Professor in the Department of Energy Engineering, Konkuk University, Republic of Korea. He earned his PhD from IIT Kharagpur.
Ranjan K. Mohapatra is Assistant Professor in Chemistry at Government College of Engineering, India. He earned PhD from Sambalpur University.
Ali Ahmed Rabaan is Head of the Molecular Diagnostic Lab at Johns Hopkins Aramco Healthcare Dhahran, Saudi Arabia, where he is also is a member of the Emerging Infectious Diseases task force. Dr. Rabaan is also adjunct Assistant Professor at the College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. He earned his PhD in Molecular Microbiology from University of Sheffield, United Kingdom.